Subject Index 407
- Membrane organelles, 125, 126, 292, 298
- Membrane protein, 216, 217, 220, 223,
275, 298, 299, 307, 312 - Membrane recycling, 202, 270, 273, 275,
307 - Membrane structure, 125, 126, 133, 207,
221, 271, 308 - Membrane trafficking, 46, 172, 199, 223,
269, 311, 314 - Membrane tubulation, 305, 314, 315
- Membrane tubule, 259
- Membranous islands, 329, 334
- Nuclear membrane, 19, 75, 207, 209, 216,
217, 219–221, 311 - Plasma membrane (PM), 33, 35, 36, 46,
47, 180, 198, 200, 208, 221, 256, 259, 261,
270, 272, 275, 276, 279, 281, 289–299,
305–308, 310, 311, 314, 330, 333, 350, 366 - Transmembrane, 217, 312, 331
Meristem, 4, 20, 61–63, 67, 199–201, 255,
257–259, 263, 264, 268, 281, 296, 328,
350, 365, 386 - Meristematic cell, 50, 143, 155, 147, 198,
201, 218, 233, 235, 258 - Meristemoid mother cells (MMC),
344–348, 351, 352, 354–357
Mesocarp, 76
Metabolism, 3, 13, 22, 59, 92, 361, 371 - Metabolic activity, 75, 76, 91
- Metabolite, 27
Metaphase, 17, 19, 21, 33, 34, 36, 45, 80, 81,
103, 108, 127, 128, 131, 133, 135, 142,
145, 146, 148, 151, 152, 154, 157, 170,
172, 173, 175, 176, 197, 199–201, 203,
212, 217, 219, 221, 222, 236, 237, 245,
258, 259, 326, 329, 333, 334, 377 - Metaphase plate, 142, 145, 151, 172, 176
- Metaphase spindle, 145, 146, 154, 157,
199, 200, 203, 329, 333 - Metaphase to anaphase transition, 13, 19,
21, 80, 334 - Postmetaphase, 329, 333
- Prometaphase, 33, 127, 142, 145, 146, 148,
152, 154, 157, 175, 176, 198, 237, 258
Metazoan, 78, 210, 334
Methylation, 66, 84, 107
MFTP (MF twin peaks), 133
MG-132 (Cell cycle-specific proteasome
inhibitor), 131
Microfibril, 127, 128, 270, 276, 353
Microfilament (MF), 33, 34, 36, 38, 40, 44,
46, 47, 49, 50, 52, 125, 126, 132, 133, 142,
150, 170, 172, 186
Microgametogenesis, 361
Microinjection, 125, 126, 132
Micromanipulation, 327
MicroRNA (miRNA), 361, 370, 382
–microRNAJAW-D, 382- miR159, 370
- miR160, 386
Microspore, 282, 323, 361–363, 365, 370–372
Microsporocyte, 279, 281, 282, 361, 364
Microsporogenesis, 361, 363, 364
Microtubule (MT), 109, 126, 129, 130, 141,
146, 170, 256 - Binding site, 128, 171, 174
- Cortical, 33–36, 41, 125, 130, 332
- Depolymerizing drug, 21, 111, 127
- Dynamics, 34, 127, 128, 182
- Fluorescence marker, 125, 173, 175, 176,
178 - Kinetochore, 142, 172, 173, 176–178, 209
- Midzone, 177–181
- Minus end, 129, 142, 144, 147, 151, 152,
171, 173, 183, 313 - Motor activity, 131, 150, 169–172, 176,
178, 182, 184, 313 - Organizing center (MTOC), 129, 130, 144,
145, 156, 157, 169, 173, 181, 261, 209,
212, 215, 220, 314 - Phragmoplast, 51, 127, 131, 169, 170, 177,
179, 180–185, 251, 255, 303, 304, 313 - Plus end, 42, 52, 142, 144, 147, 149, 151,
153, 154, 170, 171, 176, 181–183 - Polymerization, 170, 179, 242, 331
- Preprophase, 34–41, 175, 212, 221, 326,
327 - Spindle, 117, 132, 146, 147, 151, 152, 169,
170, 172–174, 196, 203, 219, 220, 255,
257, 334, 279
Microtubule-associated protein (seeMAP)
Midbody, 235, 242, 290
Middle layer, 362, 363, 365, 367, 370
Midzone, 142, 147, 148, 152, 154, 177–181,
183, 235, 241, 242, 244, 245, 313, 329, 334
Mini-phragmoplast, 258, 279, 280
Mitochondria, 195, 196, 198, 201–203, 208,
211, 255, 306, 372
Mitosis, 6, 10, 16–19, 33, 34, 36, 41–49, 52,
75–77, 80–83, 85, 88, 89, 92, 106, 108,